Skip to main content

What we do: Warwick Evidence Research Projects

Medical Devices: Hips and Knees

In our first TAR contract we worked on an MTA on Total hip replacement and resurfacing arthroplasty for the treatment of pain or disability resulting from end stage arthritis of the hip (Review of technology appraisal guidance 2 and 44, resulted in guidance TA 304).

This work resulted in a number of publications that can be viewed here and there are still more to come!


We are working on a project relating to Autologous chondrocyte implantation in the knee and

15/69/10 Autologous chondrocyte implantation with Chondrosphere for treating articular cartilage defects [ID851]

Aspirin

Our first success story followed our work on an MTA on Aspirin.


The results published by Warwick Evidence were discussed all over the world, including Azerbaiijan, Brazil, Croatia, Estonia, France, Germany, Greece, Hungary, India, Italy, Latvia, Lebanon, the Middle East, Pakistan, Peru, Poland, Portugal, Romania, Serbia, Spain, Ukraine, USA, Zimbabwe, Vietnam, and also in a lot of international journals, e.g. Hospi Medica and MTB Europe.

Gastroenterology

Warwick Evidence has worked on four projects concerning Gastroenterology:

12/08 Nutrition for Crohn disease 

12/48/01 Faecal calprotectin testing for inflammatory and non-inflammatory bowel disease

14/69/03 LISA-TRACKER

15/17/03 xTAG Gastrointestinal Pathogen Panel

Diabetes

Members of Warwick Evidence have worked on Diabetes-related projects and will be working on three more in 2018:

17/46/04: Ertugliflozin monotherapy for treating type 2 diabetes [ID1158]

17/46/05: Ertugliflozin (combination therapy with metformin) for treating type 2 diabetes [ID1159 & ID1160]

17/46/10: Liraglutide for treating diabetes type-2 cardiovascular disease [ID1197]

Dapagliflozin in Combination [ID427]

06/11/01 Non-pharmacological interventions for Diabetes

12/71 Non-proliferative diabetic retinopathy

13/60 Empagliflozin in Combination

14/148/01 Dapagliflozin in triple therapie

13/177/01 Diabetes monotherapie